The support of our valued
sponsors keeps the cost of tuition at an affordable
$75. (Even the most budget-conscious entrepreneurs can attend!) An excellent value, this workshop consists of an interactive, case-based program with opportunity for smaller group focused-networking with the 'movers-and-shakers' of the medical device community.
Sponsorship is building and presently includes:
The Ewing Marion Kauffman Foundation of Kansas City works with partners to encourage entrepreneurship across America and improve tha educational achievement of children and youth. The Kauffman Foundation was established in the mid-1960's by the late entrepreneur and philanthropist Ewing Marion Kauffman. More information about the Kauffman Foundation is available at www.kauffman.org.
Abbott Vascular Devices, a division of Abbott, is transforming the treatmentof vascular disease, combining the latest medical device innovations with world class pharmaceuticals to advance medicine and improve patient care. Abbott Vascular offers a comprehensive portfolio of vessel closure, endovascular and coronary products that are recognized internationally for their, safety, ease of use and effectiveness in treating patients with vascular disease. Abbott Vascular is headquartered in Redwood City, CA. www.abbottvascular.com
Delphi
Ventures is a venture capital firm focused on
early stage healthcare investing, including medical
devices, diagnostics and biotechnology. More
than 80 of our companies have either completed
an initial public offering or have been acquired
by leading healthcare corporations. www.delphiventures.com
The
partners at De Novo Ventures (www.denovovc.com)
truly understand the issues facing life science
entrepreneurs, as they founded and ran some of
the most successful companies in the medical device
industry, including ACS, Perclose, Origin, CTS,
and FoxHollow. De Novo invests in early stage therapeutic
medical device and biotechnology companies, and
currently has $350 million under management.
Kleiner Perkins Caufield & Byers (KPCB) is an active venture capital partnership headquartered in the San Francisco Bay Area with a large capital base for investment. Since 1972, the company has invested in over 420 technology companies which have accrued market valuations exceeding $300 billion and employ more than 285,000. www.kpcb.com
Medtronic is the world leader in medical technology providing lifelong solutions for people with chronic disease. We offer products, therapies and services that enhance or extend the lives of millions of people. Each year, 2.5 million patients benefit from Medtronic's technology, used to treat conditions such as heart disease, neurological disorders, and vascular illnesses. www.medtronic.com
Morrison & Foerster
has one of the nation’s premier life sciences
practices, focusing on corporate finance and
intellectual property protection, licensing,
and litigation. In recent years, the firm has
represented hundreds of life sciences clients
in VC financings and M&A transactions. The
firm’s Venture Intellectual Property Group,
which focuses on performing IP due diligence
for both companies and VCs, works with Morrison & Foerster's
corporate group to provide full spectrum service
for our clients. www.mofo.com
Prism VentureWorks, Westwood, MA, is a leading venture capital firm with early-stage investments in communications, business infrastructure software and systems and life sciences. With over $1 billion in capital under management, Prism has earned industry recognition through the firm's depth of entrepreneurial experience and active role with portfolio companies. Prism's access to an established pool of seasoned entrepreneurs and skilled executives, collaborative approach to working with portfolio companies and integrated network of investors contribute to the firm’s investment success. Additional information on Prism Venture Partners can be found at www.prismventure.com.
Prospect Venture Partners is a Palo Alto, California based venture capital firm with over $1 billion of capital under management. The frm is dedicated to investing in outstanding biomedical technology and life science companies. Prospect targets commercially attractive health care enterprises with outstanding entrepreneurial management teams, proprietary products, and innovative technology or services with potential for significant investment returns. The firm invests in companies with a broad range of development and financing reqirements including: (a) incubating new companies, (b) investing in first and second venture financing rounds, and (c) participating in later stage public and private companies with proven buisness models requiring expansion capital. www.prospectventures.com
Biodesign is a broad collaboration between faculty and students at Stanford who share a vision for technology innovation in biomedical engineering through, Invention & Discovery, Education, Ethics & Policy, and Technology Transfer. Our mission is to promote the invention and implementation of new health technologies through interdisciplinary research and education at the emerging frontiers of engineering and the biomedical sciences. Biodesign is a thematic area within bio-x, a program supporting multidisciplinary work related to biology. www.biodesign.stanford.edu
At Townsend we have assembled a team of attourneys who specialize in protecting your intellectual property. Most of our attourneys have technical degrees to complement their legal education, and many have advanced degrees and industry experience. We have the experience and expertise to respond to our clients specific needs, and we dedicate our best rescources and service toward meetin the goals and buisness objectives of every client. www.townsend.com
Wilson Sonsini Goodrich & Rosati's broad range of services and legal disciplines are focused on serving the principal challenges faced by management and the board of directors of business enterprises. The firm, which is headquartered in Palo Alto, California, has offices in Austin, Reston, New York City, Salt Lake City, San Diego, San Francisco and Seattle. For additional information, visit www.wsgr.com.
Founded in 1979, Advanced Technology Ventures is a bi-coastal venture capital firm with more than $1.4 billion in capital under management. We work closely with entrepreneurial teams in several technology markets, including medical devices, biotechnology, communications, software and services, and IT infrastructure to build emerging-growth business ventures into market leaders. With more than 25 years of experience, ATV has a proven track record of success in helping to build strong, sustainable business enterprises. http://www.atvcapital.com
Boston Scientific is a worldwide developer, manufacturer, and marketer of medical devices. For over 25 years Boston Scientific has advanced the process of less-invasive medicine across a wide range of medical specialties. The companies products help physicians and other medical proffessionals improve their patients' quality of life by providing alternatives to surgery that minimize risk, cost, trauma, aftercare, and procedure. www.bostonscientific.com
Canaan
Partners is an early-stage investor and creates
next-generation companies in Internet infrastructure,
communications, software and services, medical
devices, biological sciences, pharmaceuticals
and diagnostics. Founded in 1987, the firm has
invested in more than 210 companies, completed
52 mergers and acquisition, and taken 45 companies
public. Canaan was an early investor in DoubleClick
(DCLK), Immunicon (IMMC), Dexcom (DXCM) and Peninsula
Pharmaceuticals. www.canaanpartners.com
For more than 40 years, Cordis Corporation, a Johnson and Johnson company, has pioneered less invasive treatments for vascular disease. Technological innovation, and a deep understanding of the medical marketplace and the needs of patients has made Cordis the world's leading developer and manufacturer of breakthrough products for interventional medicine, minimally invasive computer-based imaging, and electrophysiology. Today 7,000 Cordis employees worldwide share a strong commitment to continue the Company's groundbreaking work in the fight against vascular disease. www.cordis.com
Organized in 1973, Johnson & Johnson Development Corporation (JJDC) is the venture capital subsidiary of Johnson & Johnson. jjdc makes private equity investments in venture funded health care companies. Portfolio companies include those in the fields of pharmaceuticals, biotechnology, medical devices, diagnostics and consumer products. JJDC also leads and manages internal investments in selected promising technologies. www.jjdevcorp.com
.Thomas,
McNerney & Partners is a health care private
equity firm investing in life science and medical
technology companies with a multi-stage investment
approach. The company has successfully funded
over 40 entities with $500 million collectively.
We provide seed-early stage funding to help entrepreneurs
launch companies and growth capital to emerging
companies for clinical development or expansion
of product commercialization. www.tm-partners.com
Three Arch Partners was formed in 1993 to provide young companies with access to relevant clinical and business resources, as well as capital. Three Arch has helped create, build and fund more than fifty important new healthcare companies. These companies have often become the clinical and market leaders in their respective fields, and have generated strong returns. The fund focuses on opportunities in medical devices and healthcare services, and less frequently in biotechnology. www.threearchpartners.com
Vanguard Ventures is an early stage venture capital firm that helps entrepreneurs build pioneering information technology and medical device companies. Since its founding in 1981, Vanguard has funded over 120 startups, including such notable companies as Ciena, Network Appliance and Zip Realty. Vanguard is interested in backing the next generation of medical device entrepreneurs. www.vanguardventures.com
Versant Ventures was founded in 1999 and is a leading health care focused venture capital firm specializing in early stage investments in medical devoces, biotechnology and pharmaceuticals. healthcare services, and healthcare informaion technology. Versant's seasoned investment team, with more than 80 years of venture capital and more than 175 years of operating experience, raised its first fund in November 1999. The firm closed a $400 million fund in December 2001, for a total of $670 million under management. Offices are located in Menlo Park and Newport Beach, California. www.versantventures.com
Founded in 1988, the vertical group is a venture capital firm that is focused on the fields of medical technology and biotechnology. The Vertical Group managesprivate partnerships with a "vertical" range of investments including: early and late venture stage companies; private operating companies involved in buy-out or corporate spin-off transactions; and public companies of all sizes. The Vertical Group has offices in Summit, NJ and Palo Alto, CA . www.vertical-group.com
Hantel is a contract medical device design and manufacturing company located in the Bay Area. Hantel expedites medical device projects by supplying services from five business units: Engineering, Fabrication, Quality/Doc Control, Manufacturing, and Regulatory. The Engineering Group is experienced in medical device development, including catheters, disposables, surgical instrumentation, electromechanical devices, fixtures, and testing. The Fabrication Group has over 190 years of machining/ prototyping experience and excels at quick-turn projects involving CNC, EDM, mold-making, and other technologies. Hantel’s Quality/ DC Group provides ISO, FDA, and Quality System auditing programs, component inspection services, and can serve as a virtual document control service. The Manufacturing Group provides CER device assembly, materials management, injection molding, and packaging services. The Regulatory Group provides regulatory strategy and documentation support. Hantel's talented multidisciplinary team operates multiple shifts to compress customer time lines, while maintaining FDA and ISO compliance. Clients work with one Hantel Group or all, depending on project scope. www.hanteltech.com
Hiemstra Product Devlopment provides design and engineering services during all stages of medical device development - from early stage feasibility, R&D and clinical builds, through design for manufacturability. Heimstra specializes in the design of unique hand held tools that require a high level of usability including catheder-based delivery systems and minimally invasive surgical devices. www.hiemstra.com
Agenda 
